Progress of oncolytic virotherapy for neuroblastoma

As a neuroendocrine tumor derived from the neural crest, neuroblastoma (NB) is the most common extracranial solid tumor in children. The prognosis in patients with low- and intermediate-risk NB is favorable while that in high-risk patients is often detrimental. However, the management of the conside...

Full description

Bibliographic Details
Published in:	Frontiers in Pediatrics
Main Authors:	Xiao-Tong Chen, Shu-Yang Dai, Yong Zhan, Ran Yang, De-Qian Chen, Yi Li, En-Qing Zhou, Rui Dong
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-11-01
Subjects:	oncolytic virus neuroblastoma mechanism preclinical clinical combination therapy
Online Access:	https://www.frontiersin.org/articles/10.3389/fped.2022.1055729/full

Similar Items

Tumor-Associated Macrophages in Oncolytic Virotherapy: Friend or Foe?
by: Nicholas L. Denton, et al.
Published: (2016-07-01)

Modern Approaches to Enterovirus-Based Oncolytic Immune Virotherapy of Malignant Diseases
by: E. R. Nemtsova, et al.
Published: (2025-07-01)

The combination therapy of oncolytic virotherapy
by: Yue Wang, et al.
Published: (2024-04-01)

Oncolytic Virotherapy for Cancer: Clinical Experience
by: Shyambabu Chaurasiya, et al.
Published: (2021-04-01)

Lung cancer and oncolytic virotherapy——enemy's enemy
by: Zhang Li, et al.
Published: (2023-01-01)

Oncolytic virotherapy in cancer treatment: challenges and optimization prospects
by: Lingjuan Chen, et al.
Published: (2023-12-01)

Enhancement of chemotherapy using oncolytic virotherapy: Mathematical and optimal control analysis
by: Joseph Malinzi, et al.
Published: (2018-11-01)

Tumor Tropism of DNA Viruses for Oncolytic Virotherapy
by: Junior A. Enow, et al.
Published: (2023-11-01)

Challenges and strategies toward oncolytic virotherapy for leptomeningeal metastasis
by: Jia-Li Zhao, et al.
Published: (2024-11-01)

Glioblastoma microenvironment and its reprogramming by oncolytic virotherapy
by: Zhongbing Qi, et al.
Published: (2022-09-01)

From Benchtop to Bedside: A Review of Oncolytic Virotherapy
by: Audrey H. Choi, et al.
Published: (2016-08-01)

Newcastle Disease Virus Virotherapy: Unveiling Oncolytic Efficacy and Immunomodulation
by: Kawther A. Zaher, et al.
Published: (2024-07-01)

Strategies for Advanced Oncolytic Virotherapy: Current Technology Innovations and Clinical Approaches
by: Qing Ji, et al.
Published: (2022-08-01)

Identification of restrictive molecules involved in oncolytic virotherapy using genome-wide CRISPR screening
by: Yiye Zhong, et al.
Published: (2024-05-01)

Oncolytic virotherapy evolved into the fourth generation as tumor immunotherapy
by: Xianwang Wang, et al.
Published: (2023-07-01)

Mechanisms, challenges and future prospects of the oncolytic virotherapy: a comprehensive review
by: Fizza Maryam, et al.
Published: (2024-06-01)

Editorial: Oncolytic virotherapy, volume II
by: Ahmed Majeed Al-Shammari, et al.
Published: (2025-01-01)

Current Status and Challenges of Oncolytic Virotherapy for the Treatment of Glioblastoma
by: Mason J. Webb, et al.
Published: (2023-05-01)

Optimizing Oncolytic Virotherapy for Malignant Glioma: From Bench to Bedside
by: Jiang W, et al.
Published: (2025-08-01)

Bovine pestivirus is a new alternative virus for multiple myeloma oncolytic virotherapy
by: Valentina Marchica, et al.
Published: (2020-07-01)

Immunosuppressive cells in oncolytic virotherapy for glioma: challenges and solutions
by: Junfeng Liu, et al.
Published: (2023-05-01)

The Role of Natural Killer Cells in Oncolytic Virotherapy: Friends or Foes?
by: Michael L. Franks, et al.
Published: (2024-06-01)

Recent progress in combination therapy of oncolytic vaccinia virus
by: Seyedeh Nasim Mirbahari, et al.
Published: (2024-03-01)

Giving Oncolytic Viruses a Free Ride: Carrier Cells for Oncolytic Virotherapy
by: Alberto Reale, et al.
Published: (2021-12-01)

Recent advances in oncolytic virus therapy for hepatocellular carcinoma
by: Licheng Zhu, et al.
Published: (2023-04-01)

Integrated re-analysis of transcriptomic and proteomic datasets reveals potential mechanisms for Zika viral-based oncolytic therapy in neuroblastoma [version 3; peer review: 1 approved, 2 approved with reservations, 1 not approved]
by: Juliet Gray, et al.
Published: (2024-05-01)

Experimental models for developing oncolytic virotherapy for metastatic prostate cancer
by: Ying-Cheng Chen, et al.
Published: (2025-07-01)

Overcoming the limitations of locally administered oncolytic virotherapy
by: JinWoo Hong, et al.
Published: (2019-07-01)

Emerging role of Natural killer cells in oncolytic virotherapy
by: Bhat R, et al.
Published: (2015-03-01)

Combining of Oncolytic Virotherapy and Other Immunotherapeutic Approaches in Cancer: A Powerful Functionalization Tactic
by: Hai Zou, et al.
Published: (2023-01-01)

Current Immunotherapeutic Strategies to Enhance Oncolytic Virotherapy
by: Daniel E. Meyers, et al.
Published: (2017-06-01)

Correction: Experimental models for developing oncolytic virotherapy for metastatic prostate cancer
by: Ying-Cheng Chen, et al.
Published: (2025-08-01)

Emerging delivery strategy for oncolytic virotherapy
by: Jiao Zhu, et al.
Published: (2024-06-01)

Comparative safety and efficacy of oncolytic virotherapy for the treatment of individuals with malignancies: a systematic review, meta-analysis, and Bayesian network meta-analysisResearch in context
by: Poyee Lau, et al.
Published: (2025-08-01)

Oncolytic viral therapy as promising immunotherapy against glioma
by: Die Hu, et al.
Published: (2023-12-01)

Oncolytic Virotherapy Treatment of Breast Cancer: Barriers and Recent Advances
by: Amy Kwan, et al.
Published: (2021-06-01)

The Feasibility of Pressurised Intraperitoneal Aerosolised Virotherapy (PIPAV) to Administer Oncolytic Adenoviruses
by: Sophia J. Tate, et al.
Published: (2021-11-01)

Oncolytic virotherapy with intratumoral injection of vaccinia virus TG6002 and 5-fluorocytosine administration in dogs with malignant tumors
by: Jérémy Béguin, et al.
Published: (2023-09-01)

Revolutionizing cancer treatment: the power of bi- and tri-specific T-cell engagers in oncolytic virotherapy
by: Ali Zarezadeh Mehrabadi, et al.
Published: (2024-02-01)

Efficacy and safety of oncolytic virus combined with chemotherapy or immune checkpoint inhibitors in solid tumor patients: A meta-analysis
by: Xiangxing Liu, et al.
Published: (2022-11-01)